AbbVie is a global, research-driven biopharmaceutical company, that came separate from Abbott in 2013, focused on developing innovative therapies for complex diseases in areas like immunology, oncology, neuroscience, and eye care, aiming to deliver significant patient impact through focused innovation and commercial scale. Headquartered in North Chicago, Illinois, AbbVie discovers, develops, manufactures, and commercializes drugs for chronic conditions and has grown into a major player in biotech, serving patients in over 175 countries.
AbbVie’s mission is to use its expertise and unique approach to create differentiated medicines and solutions for critical health challenges, improving lives. AbbVie continuously advances its pipeline with new therapies for unmet needs, supported by significant R&D efforts.
AbbVie’s values are guided by compassion, integrity, innovation, and a patient-centric approach, with strong commitments to diversity and environmental stewardship.